PHASE-II STUDY OF HIGH-DOSE 4'-EPIDOXORUBICIN IN THE TREATMENT OF ADVANCED GASTROINTESTINAL CANCER

被引:8
作者
VOROBIOF, DA [1 ]
FALKSON, G [1 ]
机构
[1] UNIV PRETORIA,DEPT MED ONCOL,PRIVATE BAG X169,PRETORIA 0001,SOUTH AFRICA
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 03期
关键词
D O I
10.1016/0277-5379(89)90271-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:563 / 564
页数:2
相关论文
共 11 条
[1]  
BANHAM SW, 1988, P ASCO, V7, P217
[2]  
BLACKSTEIN M, 1988, P AM SOC CLIN ONCOL, V7, P23
[3]  
BLACKSTEIN ME, 1987, P EUR C CLIN ONCOL, V4, P133
[4]  
Falkson G., 1984, ADV ANTHRACYCLINE CH, P105
[5]  
HOLDENER EE, 1988, P AN M AM SOC CLIN, V7, P208
[6]  
KOLARIC K, 1988, P ASCO, V7, P212
[7]  
KOLARIC K, 1984, ADV ANTHRACYCLINE CH, P111
[8]  
NOGUEIRA JAM, 1987, P ECCO, V4, P42
[9]   TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
OKEN, MM ;
CREECH, RH ;
TORMEY, DC ;
HORTON, J ;
DAVIS, TE ;
MCFADDEN, ET ;
CARBONE, PP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655
[10]  
SIMONSEN E, 1987, P ECCO, V4, P226